RBR-3q8j43招募中3 期
A multicentre, randomized, double-blind, placebo controlled, parallel group study of oral CP 690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis
Hospital de Clínicas de Porto Alegre (Centro Coordenador)0 个研究点开始时间: 2015年2月17日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •Subject must be at least 18 years of age; males and females with a documented diagnosis of ulcerative colitis (UC) at least 4 months prior to entry into the study; subjects with moderately to severely active UC based on Mayo score criteria; subjects must have failed or be intolerant of at least one of the following treatments for UC: corticosteroids (oral ou intravenous), azathioprine or 6 mercaptopurine (6MP), anti TNF alpha therapy (infliximab ou
- •adalimumab).
排除标准
- •Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings
- •suggestive of Crohn's disease; subjects with disease limited to distal 15 cm; subjects without previous treatment for UC (ie, treatment naive); subjects displaying clinical signs of fulminant colitis or toxic megacolon.
研究者
相似试验
进行中（未招募）
1 期
A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy. - REACH UPPatients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function.MedDRA version: 9.1 Level: LLT Classification code 10000803 Term: Acute heart failureEUCTR2006-006843-29-PLovaCardia Inc480
进行中（未招募）
1 期
A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy. - REACH UPPatients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function.MedDRA version: 9.1 Level: LLT Classification code 10000803 Term: Acute heart failureEUCTR2006-006843-29-GBovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc)480
进行中（未招募）
1 期
A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy. - REACH UPPatients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function.MedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failureEUCTR2006-006843-29-NLovaCardia Inc480
进行中（未招募）
不适用
A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy. - REACH UPPatients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function.MedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failureEUCTR2006-006843-29-GRovaCardia Inc480
进行中（未招募）
1 期
A multicentre, randomized, double-blind, placebo controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy. - REACH UPPatients being admitted to hospital with heart failure and volume overload requiring IV therapy after experiencing worsening of renal function.MedDRA version: 9.1Level: LLTClassification code 10000803Term: Acute heart failureEUCTR2006-006843-29-BEovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc)480